{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:24:25Z","timestamp":1775100265761,"version":"3.50.1"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>The prevalence of substandard and falsified medicines in low- and middle-income countries (LMICs) is a major global public health concern. Multiple screening technologies for post-market surveillance of medicine quality have been developed but there exists no clear guidance on which technology is optimal for LMICs. This study examined the return on investment (ROI) of implementing a select number of screening technologies for post-market surveillance of amoxicillin quality in a case study of Kenya. An agent-based model, Examining Screening Technologies using Economic Evaluations for Medicines (ESTEEM), was developed to estimate the costs, benefits, and ROI of implementing screening technologies for post-market surveillance of substandard and falsified amoxicillin for treatment of pediatric pneumonia in Kenya. The model simulated sampling, testing, and removal of substandard and falsified amoxicillin from the Kenyan market using five screening technologies: (1) Global Pharma Health Fund\u2019s GPHF-Minilab, (2) high-performance liquid chromatography (HPLC), (3) near-infrared spectroscopy (NIR), (4) paper analytical devices \/ antibiotic paper analytical devices (PADs\/aPADs), and (5) Raman spectroscopy. The study team analyzed the population impact of utilizing amoxicillin for the treatment of pneumonia in children under age five in Kenya. We found that the GPHF-Minilab, NIR, and PADs\/aPADs were similar in their abilities to rapidly screen for and remove substandard and falsified amoxicillin from the Kenyan market resulting in a higher ROI compared to HPLC. NIR and PADs\/aPADs yielded the highest ROI at $21 (90% Uncertainty Range (UR) $5-$51) each, followed by GPHF-Minilab ($16, 90%UR $4 - $38), Raman ($9, 90%UR $2 - $21), and HPLC ($3, 90%UR $0 - $7). This study highlights screening technologies that can be used to reduce costs, speed up the removal of poor-quality medicines, and consequently improve health and economic outcomes in LMICs. National medicine regulatory authorities should adopt these fast, reliable, and low-cost screening technologies to better detect substandard and falsified medicines, reserving HPLC for confirmatory tests.<\/jats:p>","DOI":"10.1371\/journal.pone.0268661","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T18:37:53Z","timestamp":1674067073000},"page":"e0268661","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study"],"prefix":"10.1371","volume":"18","author":[{"given":"Colleen R.","family":"Higgins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betty","family":"Kobia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7608-9038","authenticated-orcid":true,"given":"Sachiko","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"key":"pone.0268661.ref001","volume-title":"A study on the public health and socioeconomic impact of substandard and falsified medical products","author":"World Health Organization. WHO","year":"2017"},{"key":"pone.0268661.ref002","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.tips.2009.11.005","article-title":"Impact of poor-quality medicines in the \u2018developing\u2019 world","volume":"31","author":"PN Newton","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"pone.0268661.ref003","doi-asserted-by":"crossref","first-page":"e181662","DOI":"10.1001\/jamanetworkopen.2018.1662","article-title":"Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis","volume":"1","author":"S Ozawa","year":"2018","journal-title":"JAMA Netw Open"},{"key":"pone.0268661.ref004","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12936-016-1096-x","article-title":"Fake anti-malarials: start with the facts","volume":"15","author":"H Kaur","year":"2016","journal-title":"Malaria Journal"},{"key":"pone.0268661.ref005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4269\/ajtmh.14-0393","article-title":"Responding to the Pandemic of Falsified Medicines","volume":"92","author":"GML Nayyar","year":"2015","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"pone.0268661.ref006","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.4269\/ajtmh.21-1123","article-title":"Characterizing Medicine Quality by Active Pharmaceutical Ingredient Levels: A Systematic Review and Meta-Analysis across Low- and Middle-Income Countries","volume":"106","author":"S Ozawa","year":"2022","journal-title":"Am J Trop Med Hyg"},{"key":"pone.0268661.ref007","article-title":"Department of Maternal, Child and Adolescent Health. Revised WHO classification and treatment of pneumonia in children at health facilities: evidence summaries","author":"World Health Organization","year":"2014"},{"key":"pone.0268661.ref008","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/S2214-109X(17)30448-5","article-title":"Appropriateness of clinical severity classification of new WHO childhood pneumonia guidance: a multi-hospital, retrospective, cohort study","volume":"6","author":"A Agweyu","year":"2018","journal-title":"The Lancet Global Health"},{"key":"pone.0268661.ref009","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/S2214-109X(18)30408-X","article-title":"Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis","volume":"7","author":"DA McAllister","year":"2019","journal-title":"The Lancet Global Health"},{"key":"pone.0268661.ref010","doi-asserted-by":"crossref","first-page":"e90601","DOI":"10.1371\/journal.pone.0090601","article-title":"Technologies for Detecting Falsified and Substandard Drugs in Low and Middle-Income Countries","volume":"9","author":"S Kovacs","year":"2014","journal-title":"PLOS ONE"},{"key":"pone.0268661.ref011","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41120-019-0031-y","article-title":"Substandard and falsified medicine screening technologies","volume":"5","author":"L Roth","year":"2019","journal-title":"AAPS Open"},{"key":"pone.0268661.ref012","doi-asserted-by":"crossref","first-page":"e000725","DOI":"10.1136\/bmjgh-2018-000725","article-title":"Field detection devices for screening the quality of medicines: a systematic review","volume":"3","author":"S Vickers","year":"2018","journal-title":"BMJ Global Health"},{"key":"pone.0268661.ref013","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00216-010-3748-y","article-title":"Counterfeit drugs: analytical techniques for their identification","volume":"398","author":"R Martino","year":"2010","journal-title":"Anal Bioanal Chem"},{"key":"pone.0268661.ref014","doi-asserted-by":"crossref","first-page":"2399202620980303","DOI":"10.1177\/2399202620980303","article-title":"Cost savings of paper analytical devices (PADs) to detect substandard and falsified antibiotics: Kenya case study","volume":"5","author":"H-H Chen","year":"2021","journal-title":"Medicine Access @ Point of Care"},{"key":"pone.0268661.ref015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12992-018-0360-y","article-title":"Global landscape assessment of screening technologies for medicine quality assurance: stakeholder perceptions and practices from ten countries","volume":"14","author":"L Roth","year":"2018","journal-title":"Globalization and Health"},{"key":"pone.0268661.ref016","doi-asserted-by":"crossref","first-page":"e0009360","DOI":"10.1371\/journal.pntd.0009360","article-title":"Laboratory evaluation of twelve portable devices for medicine quality screening","volume":"15","author":"SC Zambrzycki","year":"2021","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"pone.0268661.ref017","first-page":"336","author":"Asia Development Bank (ADB)","year":"2018"},{"key":"pone.0268661.ref018","author":"UNICEF","year":"2013"},{"key":"pone.0268661.ref019","volume-title":"Amoxicillin Monograph.","author":"U.S. Pharmacopeia"},{"key":"pone.0268661.ref020","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1039\/C9AY01547G","article-title":"Lab on paper: assay of beta-lactam pharmaceuticals by redox titration","volume":"11","author":"NM Myers","year":"2019","journal-title":"Analytical Methods"},{"key":"pone.0268661.ref021","author":"United Nations Population Division Department of Economics and Social Affairs","year":"2017"},{"key":"pone.0268661.ref022","volume-title":"Kenya statistics\u2014life expectancy at birth (years) 2012","author":"UNICEF","year":"2013"},{"key":"pone.0268661.ref023","volume-title":"GDP per capita (current US$) 2016","author":"World Bank","year":"2017"},{"key":"pone.0268661.ref024","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"KL O\u2019Brien","year":"2009","journal-title":"Lancet (London, England)"},{"key":"pone.0268661.ref025","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0140-6736(12)61901-1","article-title":"Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis","volume":"381","author":"H Nair","year":"2013","journal-title":"Lancet (London, England). 2013\/02\/02 ed"},{"key":"pone.0268661.ref026","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1478-7547-7-3","article-title":"The economic burden of inpatient paediatric care in Kenya: household and provider costs for treatment of pneumonia, malaria and meningitis","volume":"7","author":"P Ayieko","year":"2009","journal-title":"Cost effectiveness and resource allocation: C\/E. 2009\/01\/24 ed."},{"key":"pone.0268661.ref027","author":"Ministry of Medical Services Pharmacy and Poisons Board","year":"2010"},{"key":"pone.0268661.ref028","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1021\/ac400989p","article-title":"Paper analytical devices for fast field screening of beta lactam antibiotics and antituberculosis pharmaceuticals","volume":"85","author":"AA Weaver","year":"2013","journal-title":"Analytical chemistry"},{"key":"pone.0268661.ref029","author":"The Technology Review Program","year":"2020"},{"key":"pone.0268661.ref030","first-page":"6","article-title":"Paper analytical devices for detection of low-quality pharmaceuticals","volume":"8976","author":"A Weaver","year":"2014","journal-title":"SPIE Proceedings"},{"key":"pone.0268661.ref031","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.4269\/ajtmh.16-0904","article-title":"A New Handheld Device for the Detection of Falsified Medicines: Demonstration on Falsified Artemisinin-Based Therapies from the Field","volume":"96","author":"BK Wilson","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"pone.0268661.ref032","doi-asserted-by":"crossref","first-page":"e0009539","DOI":"10.1371\/journal.pntd.0009539","article-title":"Implementation of field detection devices for antimalarial quality screening in Lao PDR\u2014A cost-effectiveness analysis","volume":"15","author":"N Luangasanatip","year":"2021","journal-title":"PLOS Negl Trop Dis"},{"key":"pone.0268661.ref033","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.4269\/ajtmh.16-1008","article-title":"Low Prevalence of Substandard and Falsified Antimalarial and Antibiotic Medicines in Public and Faith-Based Health Facilities of Southern Malawi","volume":"96","author":"F Khuluza","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"pone.0268661.ref034","author":"GPHF","journal-title":"GPHF-MinilabTM: Main Manual 2020 and Extensions"},{"key":"pone.0268661.ref035","doi-asserted-by":"crossref","first-page":"e0009674","DOI":"10.1371\/journal.pntd.0009674","article-title":"A comparative field evaluation of six medicine quality screening devices in Laos","volume":"15","author":"C Caillet","year":"2021","journal-title":"PLOS Negl Trop Dis"},{"key":"pone.0268661.ref036","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s12936-019-3045-y","article-title":"Usefulness of combined screening methods for rapid detection of falsified and\/or substandard medicines in the absence of a confirmatory method","volume":"18","author":"KF-M Opuni","year":"2019","journal-title":"Malaria Journal"},{"key":"pone.0268661.ref037","unstructured":"HPLC analysis according to USP and Ph. EUR. | analytics-shop.com. [cited 25 Mar 2021]. Available: https:\/\/www.analytics-shop.com\/us\/hplc-analysis-usp-ph-eur."},{"key":"pone.0268661.ref038","article-title":"The Three-Level Approach: A Framework for Ensuring Medicines Quality in Limited-Resource Countries","volume":"03","author":"VS Pribluda","year":"2014","journal-title":"Pharmaceut Reg Affairs"},{"key":"pone.0268661.ref039","author":"World Health Organization","year":"2020","journal-title":"Medicines Quality Control Laboratories. In: WHO\u2014Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control) [Internet]"},{"key":"pone.0268661.ref040","first-page":"383","article-title":"Medicines Regulation in Africa: Current State and Opportunities","volume":"31","author":"M Ndomondo-Sigonda","year":"2017","journal-title":"Pharmaceut Med."},{"key":"pone.0268661.ref041","doi-asserted-by":"crossref","first-page":"e1003747","DOI":"10.1371\/journal.pmed.1003747","article-title":"Evaluation of portable devices for medicine quality screening: Lessons learnt, recommendations for implementation, and future priorities","volume":"18","author":"C Caillet","year":"2021","journal-title":"PLOS Medicine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0268661","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T13:00:01Z","timestamp":1728738001000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0268661"}},"subtitle":[],"editor":[{"given":"Carlos Alberto","family":"Z\u00faniga-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0268661","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,18]]}}}